Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV001561457 | SCV001784066 | likely benign | not provided | 2020-01-27 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV002569015 | SCV003009493 | likely benign | Tietz syndrome; Waardenburg syndrome type 2A; Melanoma, cutaneous malignant, susceptibility to, 8 | 2024-11-21 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV004945694 | SCV005445048 | likely benign | Hereditary cancer-predisposing syndrome | 2024-12-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |